Director · Cocrystal Pharma, Inc. · Cocrystal Pharma, Inc. — Stock Options (Right to Buy)
Side
A
Value
—
Shares
24.6K
Price
—
Executed
Jan 9, 2026
Disclosed
Jan 13, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 9 executedJan 13, 2026 disclosed
COCP · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Cocrystal Pharma, Inc. — Stock Options (Right to Buy)
Ticker
COCP
Shares
24.6K
Price per share
$0
Execution date (reported)
Jan 9, 2026
Owned after transaction
24.6K shares
Days from execution to publication
4
What this establishes
Kornberg Roger D. filed this Form 4 reporting a grant or award of COCP on Jan 9, 2026. It became public on Jan 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Kornberg Roger D.cik:0001444532
Issuer
Cocrystal Pharma, Inc.cik:0001412486
Revision history · 0
No field has changed since this record was first ingested.
